Accessible Search Form           Advanced Search

  • PRINT PAGE  |  PRINT ENTIRE TOPIC  |  SHARE

Clinical Trials

The National Heart, Lung, and Blood Institute (NHLBI) is strongly committed to supporting research aimed at preventing and treating heart, lung, and blood diseases and conditions and sleep disorders.

NHLBI-supported research has led to many advances in medical knowledge and care. For example, this research has uncovered some of the causes of chronic lung diseases, as well as ways to prevent and treat these diseases.

Many more questions remain about chronic lung diseases, including COPD. The NHLBI continues to support research aimed at learning more about these diseases. For example, NHLBI-supported research on COPD includes studies that explore:

  • How certain medicines and other therapies can help treat COPD and improve quality of life for people who have the disease
  • Whether genetic factors increase the risk of lung damage that can lead to COPD
  • Whether a self-managed physical activity program is cost effective and can help people who have COPD function better
  • How a coping skills training program can improve quality of life for people who have COPD and their caregivers
  • Whether the physical properties of mucus play a role in the worsening of COPD, especially chronic bronchitis
  • How bacteria and toxins found in the lungs, mouth, and digestive system contribute to COPD and other lung diseases

Much of this research depends on the willingness of volunteers to take part in clinical trials. Clinical trials test new ways to prevent, diagnose, or treat various diseases and conditions.

For example, new treatments for a disease or condition (such as medicines, medical devices, surgeries, or procedures) are tested in volunteers who have the illness. Testing shows whether a treatment is safe and effective in humans before it is made available for widespread use.

By taking part in a clinical trial, you may gain access to new treatments before they're widely available. You also will have the support of a team of health care providers, who will likely monitor your health closely. Even if you don't directly benefit from the results of a clinical trial, the information gathered can help others and add to scientific knowledge.

If you volunteer for a clinical trial, the research will be explained to you in detail. You'll learn about treatments and tests you may receive, and the benefits and risks they may pose. You'll also be given a chance to ask questions about the research. This process is called informed consent.

If you agree to take part in the trial, you'll be asked to sign an informed consent form. This form is not a contract. You have the right to withdraw from a study at any time, for any reason. Also, you have the right to learn about new risks or findings that emerge during the trial.

For more information about clinical trials related to COPD, talk with your doctor. You also can visit the following Web sites to learn more about clinical research and to search for clinical trials:

WAS THIS HELPFUL?

  
previous topic next topic

Featured Video


Flash player 8+ and JavaScript are required to view this video

The NHLBI "Grand Opportunity" Exome Sequencing Project

COPD Logo

If you have COPD or think you might be at risk, you can take steps to make breathing easier and live a longer and more active life. Get a simple breathing test and talk with your doctor or health care provider about treatment options.

The NHLBI developed the national COPD Learn More Breathe Better® campaign to increase awareness of COPD. The campaign aims to help people with COPD and those at risk get diagnosed early, understand their treatment options, and live better with the disease.

Learn more about key campaign events, activities, and resources


COPD Clinical Trials

Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. To find clinical trials that are currently underway for COPD, visit www.clinicaltrials.gov.


COPD in the News

November 21, 2011
COPD awareness continues to rise, new NIH survey finds
Awareness of COPD (chronic obstructive pulmonary disease), the nation’s third leading killer, continues to rise in the United States, according to the results of a Web-based survey released today by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

View all COPD Press Releases


COPDGene—Research on the Role of Genetics in COPD

More than 10,000 volunteers are taking part in an NHLBI-sponsored clinical study to learn more about the role of genetics in COPD. NHLBI grantee Dr. Edwin Silverman discusses this research and the vital role that volunteers play in advancing medical knowledge in this video.

 
June 08, 2012 Last Updated Icon

The NHLBI updates Health Topics articles on a biennial cycle based on a thorough review of research findings and new literature. The articles also are updated as needed if important new research is published. The date on each Health Topics article reflects when the content was originally posted or last revised.

Twitter iconTwitter         Facebook iconFacebook         YouTube iconYouTube